{"meta":{"query_hash":"b0be9f2b761b","filters":{"venue":"Neoplasma"},"cohort_total":5,"direct_labels_cover":0,"predictions_cover":5,"exported":5,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/b0be9f2b761b","api":"https://metacan.xera.ac/api/v1/cohort?venue=Neoplasma"},"results":[{"id":"W2318561906","doi":"10.4149/neo_2010_06_590","title":"Endoglin and CD-34 immunoreactivity in the assessment of microvessel density in normal pituitary and adenoma subtypes","year":2010,"lang":"en","type":"article","venue":"Neoplasma","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Endoglin; Angiogenesis; Pathology; Immunohistochemistry; Adenoma; Pituitary adenoma; CD34; Pituitary tumors; Microvessel; Pituitary neoplasm; Medicine; Pituitary gland; Internal medicine; Biology; Hormone","score_opus":0.0066556922757678195,"score_gpt":0.25213864238706885,"score_spread":0.24548295011130103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318561906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963586,0.0002861993,0.0000018370392,0.0003916836,0.00005060604,0.0002616882,0.000011083654,0.0000055069854,0.0026328256],"genre_scores_gemma":[0.9992313,0.0001329322,0.00045784918,0.00010456761,0.000017503724,0.0000107518235,0.00001759906,0.0000060076527,0.000021533036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993525,0.000040554147,0.00015870159,0.00017413161,0.000115572184,0.00015852423],"domain_scores_gemma":[0.99956405,0.00014789223,0.000045382192,0.00018238639,0.000017057077,0.00004320544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020150884,0.00011390617,0.00023743854,0.00008233088,0.0000360634,0.000009364959,0.000048943173,0.00007559322,0.000012460406],"category_scores_gemma":[0.000027315744,0.00007737172,0.000025492076,0.00008714562,0.000086196975,0.000092244205,0.00004044353,0.000280213,0.0000010603956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013923344,0.00046842595,0.98088115,0.000039561408,0.000023220362,0.00012580541,0.00045298928,2.598407e-7,0.013829035,0.0001823708,0.000024233645,0.0038337067],"study_design_scores_gemma":[0.003091541,0.00020326534,0.9940115,0.000023359025,0.00003599623,0.00022741397,0.00031180665,0.00011881363,0.001558071,0.00026838176,0.00008196671,0.000067846275],"about_ca_topic_score_codex":0.0017064012,"about_ca_topic_score_gemma":0.007602157,"teacher_disagreement_score":0.01313038,"about_ca_system_score_codex":0.000015692702,"about_ca_system_score_gemma":0.00006341196,"threshold_uncertainty_score":0.4242182},"labels":[],"label_agreement":null},{"id":"W2886880347","doi":"10.4149/neo_2018_170822n551","title":"TMEM45B is a novel predictive biomarker for prostate cancer progression and metastasis","year":2018,"lang":"en","type":"article","venue":"Neoplasma","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"National Natural Science Foundation of China","keywords":"Prostate cancer; Medicine; Biomarker; Clinical significance; Oncology; Metastasis; Internal medicine; Biochemical recurrence; Logistic regression; Cancer; Prostatectomy; Biology","score_opus":0.046944165663513567,"score_gpt":0.3831711671102199,"score_spread":0.33622700144670636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886880347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869227,0.0021189826,0.0002705337,0.005741407,0.00024657592,0.0024793835,0.0006462506,0.00007787198,0.0014963403],"genre_scores_gemma":[0.985283,0.00081337296,0.004422691,0.00048054694,0.00030962794,0.0012613268,0.0000726216,0.000048646765,0.0073081474],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99886423,0.000012625099,0.00014723127,0.000369449,0.00024913537,0.0003573431],"domain_scores_gemma":[0.9992385,0.00005299646,0.00005627241,0.0001714203,0.00029465315,0.00018614902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013899668,0.00015982802,0.00022789653,0.0001056721,0.00016372591,0.000030508247,0.000045742207,0.00007964936,0.00015347217],"category_scores_gemma":[0.000038359518,0.000104683146,0.00006075125,0.00019679798,0.00025876044,0.000094548675,0.000055713455,0.00008236616,0.000010747998],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021444354,0.0008562466,0.15199046,0.00091954437,0.0017191172,0.00003641504,0.006682101,4.063003e-7,0.070089675,0.000090005866,0.057637874,0.6885338],"study_design_scores_gemma":[0.029799158,0.008743381,0.1266465,0.0011241575,0.0010505064,0.00014583621,0.0006508473,0.01075496,0.40815896,0.00031185464,0.41203895,0.00057488115],"about_ca_topic_score_codex":0.000043203312,"about_ca_topic_score_gemma":0.000030904164,"teacher_disagreement_score":0.6879589,"about_ca_system_score_codex":0.00009042661,"about_ca_system_score_gemma":0.00021565273,"threshold_uncertainty_score":0.42688546},"labels":[],"label_agreement":null},{"id":"W2980342814","doi":"10.4149/neo_2019_190309n203","title":"Chromosome 17 centromere amplification and chromosomal instability (CIN) in breast cancer: Pathogenic and therapeutic implications","year":2019,"lang":"en","type":"article","venue":"Neoplasma","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sault Area Hospital; Essar Steel Algoma (Canada); NOSM University","funders":"","keywords":"Centromere; Polysomy; Chromosome instability; Breast cancer; Biology; Cancer; Gene duplication; Chromosome; Aneuploidy; Genetics; Cancer research; Oncology; Medicine; Fluorescence in situ hybridization; Gene","score_opus":0.006784070859695528,"score_gpt":0.21908607782741657,"score_spread":0.21230200696772103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980342814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99724245,0.000854802,0.000011976653,0.00088857,0.00006414334,0.0003059145,0.00025798194,0.000011658298,0.00036252642],"genre_scores_gemma":[0.99863946,0.00064906327,0.000086436725,0.00016100868,0.000070363334,0.00007676499,0.00010454715,0.000015344167,0.00019700258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908274,0.00004451999,0.00020638478,0.00038965934,0.00006147644,0.00021522045],"domain_scores_gemma":[0.9994806,0.000014471913,0.00007228625,0.00031501264,0.00004869029,0.00006890704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008541971,0.00014378855,0.00014696103,0.000039538372,0.0000789488,0.00003640652,0.00009580435,0.00012070929,0.00010390028],"category_scores_gemma":[0.000004463695,0.00014153193,0.000032139495,0.00009256104,0.00006632802,0.000010357236,0.000079241945,0.00007913703,0.00000897912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048132148,0.000066233195,0.5848405,0.00004394064,0.000027990212,3.5272421e-7,0.00022507699,0.000038627153,0.40859294,0.0010335447,0.000025945023,0.0050567593],"study_design_scores_gemma":[0.0007576385,0.00007546393,0.9921822,0.000012227902,0.000015917198,0.00010419734,0.00019599104,0.00015559846,0.0035991606,0.00018644321,0.0025316994,0.00018344674],"about_ca_topic_score_codex":0.00011810322,"about_ca_topic_score_gemma":0.00021859443,"teacher_disagreement_score":0.40734175,"about_ca_system_score_codex":0.000037617898,"about_ca_system_score_gemma":0.000089294634,"threshold_uncertainty_score":0.5771504},"labels":[],"label_agreement":null},{"id":"W2980900961","doi":"10.4149/neo_2019_190110n34","title":"Evidence of β-blockers drug repurposing for the treatment of triple negative breast cancer: A systematic review","year":2019,"lang":"en","type":"review","venue":"Neoplasma","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Repurposing; Breast cancer; Triple-negative breast cancer; Oncology; Drug repositioning; Internal medicine; Clinical trial; In vivo; Cancer; Metastasis; Observational study; Drug; Pharmacology","score_opus":0.07109275791822826,"score_gpt":0.36846849762571493,"score_spread":0.29737573970748665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980900961","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000027077302,0.98385555,0.0000035654493,0.0004241061,0.00046004733,0.0149729075,0.00021322284,0.000018356826,0.000025169249],"genre_scores_gemma":[0.000012034681,0.99271,0.00008177177,0.000057975052,0.00020514024,0.002838336,0.00001894291,0.00006907943,0.0040067337],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9968336,0.00040630074,0.0016078018,0.00043363863,0.0004214756,0.00029713486],"domain_scores_gemma":[0.99259317,0.0036794469,0.0020628062,0.0012566311,0.00032998755,0.00007795892],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005919966,0.00052993797,0.006069031,0.00014954682,0.00007305041,0.0000137925545,0.00031592502,0.00015411459,0.00005439743],"category_scores_gemma":[0.00049073884,0.00028381334,0.0018222105,0.00045427697,0.00015539434,0.000060508857,0.00002313438,0.0001533676,0.000011902674],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004375524,0.00009983355,0.0000033084666,0.7306152,0.0009460728,0.0000038920325,0.00033805618,3.379157e-7,6.9350534e-7,0.0000030979086,0.0015752059,0.26597676],"study_design_scores_gemma":[0.0007556725,0.00053658546,0.0000030998733,0.7299699,0.02286603,0.0004927788,0.00011356927,0.000020667108,0.00002968625,5.5757334e-7,0.24504218,0.00016926433],"about_ca_topic_score_codex":0.00065906934,"about_ca_topic_score_gemma":0.000062230865,"teacher_disagreement_score":0.2658075,"about_ca_system_score_codex":0.0005745201,"about_ca_system_score_gemma":0.0017374251,"threshold_uncertainty_score":0.9999614},"labels":[],"label_agreement":null},{"id":"W3189694561","doi":"10.4149/neo_2021_210205n180","title":"Alpha-fetoprotein/endoplasmic reticulum stress signaling mitigates injury in hepatoma cells","year":2021,"lang":"en","type":"article","venue":"Neoplasma","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Chinese Foundation for Hepatitis Prevention and Control; Petroleum Technology Research Centre; National Natural Science Foundation of China","keywords":"Unfolded protein response; Endoplasmic reticulum; Thapsigargin; Apoptosis; Necroptosis; Gene knockdown; Cell biology; Chemistry; Programmed cell death; Cell growth; Alpha-fetoprotein; Cancer research; Biology; Molecular biology; Hepatocellular carcinoma; Biochemistry","score_opus":0.00434639496520042,"score_gpt":0.22212228899172826,"score_spread":0.21777589402652783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3189694561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957447,0.0010267525,0.00008997912,0.00019286267,0.00038929927,0.00024271346,0.00018480646,0.000030288986,0.002098587],"genre_scores_gemma":[0.99664044,0.000467127,0.0009826312,0.00034948514,0.00022993247,0.00007778913,0.0002915204,0.000053705986,0.00090738625],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977346,0.0001523422,0.00046247366,0.00077825633,0.00028307326,0.00058922876],"domain_scores_gemma":[0.9988304,0.000038391037,0.00012433364,0.00060665415,0.00013792858,0.0002622904],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012673215,0.0003401832,0.00032104642,0.00008372701,0.00009904206,0.00008321047,0.00025588734,0.0002649324,0.00023211908],"category_scores_gemma":[0.00013601471,0.0003556084,0.0001980577,0.0002123878,0.00011601986,0.000011358318,0.00021805648,0.00022912616,0.000087240245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014910314,0.00023354472,0.043268267,0.00010736566,0.00004999292,0.0004992085,0.0000629567,0.00058037176,0.95266104,0.00011709999,0.0013438814,0.00092715217],"study_design_scores_gemma":[0.0010968022,0.00014006195,0.0013907802,0.00012258494,0.000028308574,0.000060711332,0.00023764555,0.0004892732,0.99060637,0.00010911595,0.0052933996,0.0004249616],"about_ca_topic_score_codex":0.000072727504,"about_ca_topic_score_gemma":0.0002107692,"teacher_disagreement_score":0.04187749,"about_ca_system_score_codex":0.000026312966,"about_ca_system_score_gemma":0.0002573426,"threshold_uncertainty_score":0.9998896},"labels":[],"label_agreement":null}]}